QS Investors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$6.35M Buy
12,587
+263
+2% +$124K 0.08% 197
2021
Q1
$5.63M Buy
12,324
+89
+0.7% +$42.5K 0.07% 221
2020
Q4
$5.7M Buy
12,235
+473
+4% +$222K 0.07% 204
2020
Q3
$5.19M Sell
11,762
-2,175
-16% -$899K 0.07% 195
2020
Q2
$5.05M Sell
13,937
-154
-1% -$51.6K 0.07% 212
2020
Q1
$4M Sell
14,091
-2,406
-15% -$759K 0.06% 242
2019
Q4
$5.38M Sell
16,497
-99
-0.6% -$30K 0.05% 254
2019
Q3
$4.83M Sell
16,596
-600
-3% -$172K 0.05% 287
2019
Q2
$5.05M Buy
17,196
+1,300
+8% +$358K 0.05% 266
2019
Q1
$4.35M Sell
15,896
-533
-3% -$133K 0.05% 313
2018
Q4
$3.68M Sell
16,429
-17
-0.1% -$3.99K 0.05% 308
2018
Q3
$4.01M Sell
16,446
-687
-4% -$158K 0.04% 358
2018
Q2
$3.55M Sell
17,133
-1,267
-7% -$269K 0.04% 409
2018
Q1
$3.8M Sell
18,400
-1,404
-7% -$295K 0.04% 351
2017
Q4
$3.76M Buy
19,804
+865
+5% +$166K 0.04% 393
2017
Q3
$3.58M Sell
18,939
-5
-0% -$906 0.03% 413
2017
Q2
$3.31M Buy
18,944
+684
+4% +$115K 0.03% 433
2017
Q1
$2.81M Buy
18,260
+9,746
+114% +$1.49M 0.02% 498
2016
Q4
$1.2M Hold
8,514
0.01% 722
2016
Q3
$1.35M Buy
8,514
+179
+2% +$27.6K 0.01% 723
2016
Q2
$1.23M Buy
8,335
+24
+0.3% +$3.54K 0.01% 741
2016
Q1
$1.18M Buy
8,311
+703
+9% +$94.2K 0.01% 736
2015
Q4
$1.08M Buy
7,608
+113
+2% +$15.1K 0.01% 787
2015
Q3
$916K Hold
7,495
0.01% 800
2015
Q2
$973K Sell
7,495
-1,100
-13% -$143K 0.01% 765
2015
Q1
$1.15M Sell
8,595
-100
-1% -$12.9K 0.01% 710
2014
Q4
$1.09M Sell
8,695
-7,000
-45% -$851K 0.01% 708
2014
Q3
$1.91M Sell
15,695
-111,200
-88% -$13.5M 0.05% 248
2014
Q2
$15M Sell
126,895
-122,873
-49% -$14.5M 0.4% 66
2014
Q1
$30M Buy
249,768
+237,400
+1,919% +$28.2M 0.9% 24
2013
Q4
$1.38M Sell
12,368
-1,400
-10% -$139K 0.05% 265
2013
Q3
$1.27M Sell
13,768
-632
-4% -$57.2K 0.05% 284
2013
Q2
$1.25M Buy
+14,400
New +$1.2M 0.04% 351

Other funds holding TMO

QS Investors's TMO Position: Q2 2021 in Review

QS Investors increased its Thermo Fisher Scientific (TMO) stake by 2.1% in Q2 2021, buying an estimated $124K and bringing the position to 12,587 shares worth $6.35M. The position accounts for 0.08% of the portfolio, ranked #197.

QS Investors first reported a position in TMO in Q2 2013 and has held it in 33 quarters since. The position peaked at $30M in Q1 2014. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • QS Investors held 12,587 shares of Thermo Fisher Scientific worth $6.35M as of Q2 2021.
  • QS Investors bought 263 Thermo Fisher Scientific shares in Q2 2021, an estimated $124K.
  • Thermo Fisher Scientific made up 0.08% of QS Investors's portfolio in Q2 2021, its #197 holding.
  • QS Investors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 33 quarters since.
  • QS Investors's Thermo Fisher Scientific position peaked at $30M in Q1 2014.
  • 2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.